Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice

Behavioural Brain Research

Volumn 216, Issue 2, 2011, Pages 585-591

  Christiansen, S H ^a   Olesen, M V ^a   Wortwein G ^a   Woldbye, D P D ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Chronic restraint stress; Depression; Fluoxetine; Galanin; NPY

Indexed keywords

FLUOXETINE; GALANIN; MESSENGER RNA; NEUROPEPTIDE Y;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DRUG MECHANISM; GENE EXPRESSION REGULATION; IMMOBILIZATION STRESS; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRIFORM CORTEX;

AMYGDALA; ANIMALS; BRAIN; DENTATE GYRUS; DEPRESSION; FLUOXETINE; GALANIN; MALE; MICE; NEUROPEPTIDE Y; PARAHIPPOCAMPAL GYRUS; RESTRAINT, PHYSICAL; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; TEMPORAL LOBE;

EID: 78149496717     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.08.044     Document Type: Article

References (50)

1. Schloss P., Henn F.A. New insights into the mechanisms of antidepressant therapy. Pharmacol Ther 2004, 102:47-60.
2. Gillespie N.A., Whitfield J.B., Williams B., Heath A.C., Martin N.G. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med 2005, 35:101-111.
3. Mello A.A., Mello M.F., Carpenter L.L., Price L.H. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Rev Bras Psiquiatr 2003, 25:231-238.
4. Rotzinger S., Lovejoy D.A., Tan L.A. Behavioral effects of neuropeptides in, rodent models of depression and anxiety. Peptides 2009, 31:736-756.
5. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
6. Lin S., Boey D., Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 2004, 38:189-200.
7. Woldbye D.P., Madsen T.M., Larsen P.J., Mikkelsen J.D., Bolwig T.G. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res 1996, 737:162-168.
8. Mazarati A.M., Hohmann J.G., Bacon A., Liu H., Sankar R., Steiner R.A., et al. Modulation of hippocampal excitability and seizures by galanin. J Neurosci 2000, 20:6276-6281.
9. Primeaux S.D., York D.A., Bray G.A. Neuropeptide Y administration into the amygdala alters high fat food intake. Peptides 2006, 27:1644-1651.
10. Poritsanos N.J., Mizuno T.M., Lautatzis M.E., Vrontakis M. Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. Int J Obes (Lond) 2009, 33:1381-1389.
11. Gundlach A.L., Burazin T.C., Larm J.A. Distribution, regulation and role of hypothalamic galanin systems: renewed interest in a pleiotropic peptide family. Clin Exp Pharmacol Physiol 2001, 28:100-105.
12. Walf A.A., Frye C.A. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006, 31:1097-1111.
13. Wang D., Noda Y., Tsunekawa H., Zhou Y., Miyazaki M., Senzaki K., et al. Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behav Brain Res 2007, 178:262-273.
14. Picciotto M.R., Brabant C., Einstein E.B., Kamens H.M., Neugebauer N.M. Effects of galanin on monoaminergic systems and HPA axis: potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors. Brain Res 2010, 1314:206-218.
15. Redrobe J.P., Dumont Y., Fournier A., Baker G.B., Quirion R. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides 2005, 26:1394-1400.
16. Schmidt M.V., Liebl C., Sterlemann V., Ganea K., Hartmann J., Harbich D., et al. Neuropeptide Y mediates the initial hypothalamic-pituitary-adrenal response to maternal separation in the neonatal mouse. J Endocrinol 2008, 197:421-427.
17. Thorsell A., Carlsson K., Ekman R., Heilig M. Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport 1999, 10:3003-3007.
18. Thorsell A., Svensson P., Wiklund L., Sommer W., Ekman R., Heilig M. Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul Pept 1998, 75-76:247-254.
19. Husum H., Mikkelsen J.D., Hogg S., Mathe A.A., Mork A. Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram. Neuropharmacology 2000, 39:1463-1473.
20. Ishida H., Shirayama Y., Iwata M., Katayama S., Yamamoto A., Kawahara R., et al. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor. Hippocampus 2007, 17:271-280.
21. Stogner K.A., Holmes P.V. Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacol 2000, 387:R9-10.
22. Kozlovsky N., Matar M.A., Kaplan Z., Zohar J., Cohen H. The role of the galaninergic system in modulating stress-related responses in an animal model of posttraumatic stress disorder. Biol Psychiatry 2009, 65:383-391.
23. Kuteeva E., Wardi T., Lundstrom L., Sollenberg U., Langel U., Hokfelt T., et al. Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level. Neuropsychopharmacology 2008, 33:2573-2585.
24. Holmes P.V., Blanchard D.C., Blanchard R.J., Brady L.S., Crawley J.N. Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus. Pharmacol Biochem Behav 1995, 50:655-660.
25. Son G.H., Geum D., Chung S., Kim E.J., Jo J.H., Kim C.M., et al. Maternal stress produces learning deficits associated with impairment of NMDA receptor-mediated synaptic plasticity. J Neurosci 2006, 26:3309-3318.
26. Sweerts B.W., Jarrott B., Lawrence A.J. Acute and chronic restraint stress: effects on [125I] -galanin binding in normotensive and hypertensive rat brain. Brain Res 2000, 873:318-329.
27. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23:238-245.
28. Ulrich-Lai Y.M., Figueiredo H.F., Ostrander M.M., Choi D.C., Engeland W.C., Herman J.P. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab 2006, 291:E965-E973.
29. Haenisch B., Bilkei-Gorzo A., Caron M.G., Bonisch H. Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J Neurochem 2009, 111:403-416.
30. Kim K.S., Han P.L. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J Neurosci Res 2006, 83:497-507.
31. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001, 11:240-249.
32. Harrison P.J. The neuropathology of primary mood disorder. Brain 2002, 125:1428-1449.
33. Jarosik J., Legutko B., Unsicker K., von Bohlen Und Halbach O. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy. Exp Neurol 2007, 204:20-28.
34. Holmes P.V., Crawley J.N. Olfactory bulbectomy increases prepro-galanin mRNA levels in the rat locus coeruleus. Brain Res Mol Brain Res 1996, 36:184-188.
35. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85:367-370.
36. Paxinos G., Franklin K. The Mouse Brain - in Stereotaxic Coordinates 2001, Academic Press, San Diego.
37. Christensen D.Z., Olesen M.V., Kristiansen H., Mikkelsen J.D., Woldbye D.P. Unaltered neuropeptide Y (NPY)-stimulated [35S] GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice. J Neurosci Res 2006, 84:1282-1291.
38. Mikkelsen J.D., Woldbye D.P. Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation. J Psychiatr Res 2006, 40:153-159.
39. Kaplan L.M., Spindel E.R., Isselbacher K.J., Chin W.W. Tissue-specific expression of the rat galanin gene. Proc Natl Acad Sci USA 1988, 85:1065-1069.
40. Tuli J.S., Smith J.A., Morton D.B. Effects of acute and chronic restraint on the adrenal gland weight and serum corticosterone concentration of mice and their faecal output of oocysts after infection with Eimeria apionodes. Res Vet Sci 1995, 59:82-86.
41. Zucchi F.C., Kirkland S.W., Jadavji N.M., van Waes L.T., Klein A., Supina R.D., et al. Predictable stress versus unpredictable stress: a comparison in a rodent model of stroke. Behav Brain Res 2009, 205:67-75.
42. Sweerts B.W., Jarrott B., Lawrence A.J. Expression of preprogalanin mRNA following acute and chronic restraint stress in brains of normotensive and hypertensive rats. Brain Res Mol Brain Res 1999, 69:113-123.
43. Stone E.A., Lehmann M.L., Lin Y., Quartermain D. Reduced evoked fos expression in activity-related brain regions in animal models of behavioral depression. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1196-1207.
44. Primeaux S.D., Holmes P.V. Olfactory bulbectomy increases met-enkephalin- and neuropeptide-Y-like immunoreactivity in rat limbic structures. Pharmacol Biochem Behav 2000, 67:331-337.
45. Holmes P.V., Davis R.C., Masini C.V., Primeaux S.D. Effects of olfactory bulbectomy on neuropeptide gene expression in the rat olfactory/limbic system. Neuroscience 1998, 86:587-596.
46. Caberlotto L., Fuxe K., Overstreet D.H., Gerrard P., Hurd Y.L. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Brain Res Mol Brain Res 1998, 59:58-65.
47. Lu X., Barr A.M., Kinney J.W., Sanna P., Conti B., Behrens M.M., et al. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci USA 2005, 102:874-879.
48. Zambello E., Fuchs E., Abumaria N., Rygula R., Domenici E., Caberlotto L. Chronic psychosocial stress alters NPY system: different effects in rat and tree shrew. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:122-130.
49. Lowry C.A., Hale M.W., Evans A.K., Heerkens J., Staub D.R., Gasser P.J., et al. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann N Y Acad Sci 2008, 1148:86-94.
50. Mathe A.A. Neuropeptides and electroconvulsive treatment. J ECT 1999, 15:60-75.